{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:44Z","timestamp":1781647064173,"version":"3.54.5"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Barrett\u2019s esophagus (BE) is the only known precursor for esophageal adenocarcinoma. Patients diagnosed in endoscopy-based screening and surveillance programs have improved outcomes, but there are many limitations with current screening and surveillance paradigms. This review examines novel technologies aimed at improving current BE screening and surveillance strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>BE risk stratification algorithms have decent discriminatory performance but are cumbersome to implement. Non-endoscopic screening tools, including swallowable cell collection devices, have shown good sensitivity and cost-effectiveness. Early studies of serum biomarkers, such as microRNA assays, have yielded promising results but warrant further validation. WATS-3D appears to increase dysplasia yield among patients undergoing surveillance. Tissue-based biomarkers may assist in risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Novel, non-endoscopic technologies have the potential to enrich the BE screening population and improve outcomes, although most require further validation. Collaboration with primary care providers is critical to maximize the impact of such interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11894-026-01041-6","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:29:23Z","timestamp":1775478563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Practical Guide to Incorporating Novel Barrett\u2019s Screening\/Surveillance Tools into Clinical Practice"],"prefix":"10.1007","volume":"28","author":[{"given":"Brian E.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Strauss Starling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"8","key":"1041_CR1","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ajg.2017.155","volume":"112","author":"M Arnold","year":"2017","unstructured":"Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol. 2017;112(8):1247\u201355. https:\/\/doi.org\/10.1038\/ajg.2017.155.","journal-title":"Am J Gastroenterol"},{"key":"1041_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canep.2016.01.013","volume":"41","author":"AP Thrift","year":"2016","unstructured":"Thrift AP. The epidemic of oesophageal carcinoma: Where are we now? Cancer Epidemiol. 2016;41:88\u201395. https:\/\/doi.org\/10.1016\/j.canep.2016.01.013.","journal-title":"Cancer Epidemiol"},{"issue":"15","key":"1041_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM, S\u00f8rensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N Engl J Med. 2011;365(15):1375\u201383. https:\/\/doi.org\/10.1056\/NEJMoa1103042.","journal-title":"N Engl J Med"},{"issue":"8","key":"1041_CR4","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1053\/j.gastro.2018.02.022","volume":"154","author":"DC Codipilly","year":"2018","unstructured":"Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, et al. The Effect of Endoscopic Surveillance in Patients With Barrett\u2019s Esophagus: A Systematic Review and Meta-analysis. Gastroenterology. 2018;154(8):2068\u2013e865. https:\/\/doi.org\/10.1053\/j.gastro.2018.02.022.","journal-title":"Gastroenterology"},{"issue":"11","key":"1041_CR5","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s10620-018-5241-y","volume":"63","author":"TN Wenker","year":"2018","unstructured":"Wenker TN, Tan MC, Liu Y, El-Serag HB, Thrift AP. Prior Diagnosis of Barrett\u2019s Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival. Dig Dis Sci. 2018;63(11):3112\u20139. https:\/\/doi.org\/10.1007\/s10620-018-5241-y.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"1041_CR6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/cam4.4484","volume":"11","author":"J Offman","year":"2022","unstructured":"Offman J, Pesola F, Fitzgerald RC, Hamilton W, Sasieni P. Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study. Cancer Med. 2022;11(4):1160\u201371. https:\/\/doi.org\/10.1002\/cam4.4484.","journal-title":"Cancer Med"},{"issue":"22","key":"1041_CR7","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa0808145","volume":"360","author":"NJ Shaheen","year":"2009","unstructured":"Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277\u201388. https:\/\/doi.org\/10.1056\/NEJMoa0808145.","journal-title":"N Engl J Med"},{"issue":"1","key":"1041_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2013.03.046","volume":"145","author":"KN Phoa","year":"2013","unstructured":"Phoa KN, Pouw RE, van Vilsteren FGI, Sondermeijer CMT, Ten Kate FJW, Visser M, et al. Remission of Barrett\u2019s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology. 2013;145(1):96\u2013104. https:\/\/doi.org\/10.1053\/j.gastro.2013.03.046.","journal-title":"Gastroenterology"},{"issue":"12","key":"1041_CR9","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1007\/s10620-023-08107-9","volume":"68","author":"ZL Smith","year":"2023","unstructured":"Smith ZL, Thorgerson AM, Dawson AZ, Wani S. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett\u2019s Esophagus Patients Undergoing Endoscopic Eradication Therapy. Dig Dis Sci. 2023;68(12):4439\u201348. https:\/\/doi.org\/10.1007\/s10620-023-08107-9.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1041_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtcvs.2010.08.058","volume":"141","author":"J Zehetner","year":"2011","unstructured":"Zehetner J, DeMeester SR, Hagen JA, Ayazi S, Augustin F, Lipham JC, et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg. 2011;141(1):39\u201347. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.08.058.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"1041_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.gie.2019.05.012","volume":"90","author":"B Qumseya","year":"2019","unstructured":"Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S, et al. ASGE guideline on screening and surveillance of Barrett\u2019s esophagus. Gastrointest Endosc. 2019;90(3):335\u2013e592. https:\/\/doi.org\/10.1016\/j.gie.2019.05.012.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"1041_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.14309\/ajg.0000000000001680","volume":"117","author":"NJ Shaheen","year":"2022","unstructured":"Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, et al. Diagnosis and Management of Barrett\u2019s Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022;117(4):559\u201387. https:\/\/doi.org\/10.14309\/ajg.0000000000001680.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1041_CR13","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.cgh.2022.06.003","volume":"20","author":"VR Muthusamy","year":"2022","unstructured":"Muthusamy VR, Wani S, Gyawali CP, Komanduri S. AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett\u2019s Esophagus: Expert Review. Clin Gastroenterol Hepatol. 2022;20(12):2696\u2013e7061. https:\/\/doi.org\/10.1016\/j.cgh.2022.06.003.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1041_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","volume":"63","author":"RC Fitzgerald","year":"2014","unstructured":"Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus. Gut. 2014;63(1):7\u201342. https:\/\/doi.org\/10.1136\/gutjnl-2013-305372.","journal-title":"Gut"},{"key":"1041_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331557","author":"M di Pietro","year":"2024","unstructured":"di Pietro M, Trudgill NJ, Vasileiou M, Longcroft-Wheaton G, Phillips AW, Gossage J, et al. National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett\u2019s oesophagus and stage I oesophageal adenocarcinoma. Gut. 2024. https:\/\/doi.org\/10.1136\/gutjnl-2023-331557.","journal-title":"Gut"},{"issue":"12","key":"1041_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1055\/a-2176-2440","volume":"55","author":"B Weusten","year":"2023","unstructured":"Weusten B, Bisschops R, Dinis-Ribeiro M, di Pietro M, Pech O, Spaander MCW, et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2023;55(12):1124\u201346. https:\/\/doi.org\/10.1055\/a-2176-2440.","journal-title":"Endoscopy"},{"issue":"6","key":"1041_CR17","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1053\/j.gastro.2024.03.019","volume":"166","author":"JH Rubenstein","year":"2024","unstructured":"Rubenstein JH, Sawas T, Wani S, Eluri S, Singh S, Chandar AK, et al. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett\u2019s Esophagus and Related Neoplasia. Gastroenterology. 2024;166(6):1020\u201355. https:\/\/doi.org\/10.1053\/j.gastro.2024.03.019.","journal-title":"Gastroenterology"},{"issue":"1","key":"1041_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/apt.15760","volume":"52","author":"MC Tan","year":"2020","unstructured":"Tan MC, Mansour N, White DL, Sisson A, El-Serag HB, Thrift AP. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett\u2019s oesophagus in oesophageal adenocarcinoma patients. Aliment Pharmacol Ther. 2020;52(1):20\u201336. https:\/\/doi.org\/10.1111\/apt.15760.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"1041_CR19","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.14309\/ajg.0000000000001998","volume":"117","author":"JH Rubenstein","year":"2022","unstructured":"Rubenstein JH. Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma. Am J Gastroenterol. 2022;117(11):1759\u201361. https:\/\/doi.org\/10.14309\/ajg.0000000000001998.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1041_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.14309\/ajg.0000000000002159","volume":"118","author":"SJ Spechler","year":"2023","unstructured":"Spechler SJ, El-Serag HB. Why Has Screening and Surveillance for Barrett\u2019s Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma? Am J Gastroenterol. 2023;118(4):590\u20132. https:\/\/doi.org\/10.14309\/ajg.0000000000002159.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"1041_CR21","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.14309\/ajg.0000000000001935","volume":"117","author":"S Eluri","year":"2022","unstructured":"Eluri S, Reddy S, Ketchem CC, Tappata M, Nettles HG, Watts AE, et al. Low Prevalence of Endoscopic Screening for Barrett\u2019s Esophagus in a Screening-Eligible Primary Care Population. Am J Gastroenterol. 2022;117(11):1764\u201371. https:\/\/doi.org\/10.14309\/ajg.0000000000001935.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1041_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.gie.2020.06.032","volume":"93","author":"TH Nguyen","year":"2021","unstructured":"Nguyen TH, Thrift AP, Rugge M, El-Serag HB. Prevalence of Barrett\u2019s esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc. 2021;93(2):409\u2013e191. https:\/\/doi.org\/10.1016\/j.gie.2020.06.032.","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"1041_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.gie.2019.05.030","volume":"90","author":"BJ Qumseya","year":"2019","unstructured":"Qumseya BJ, Bukannan A, Gendy S, Ahemd Y, Sultan S, Bain P, et al. Systematic review and meta-analysis of prevalence and risk factors for Barrett\u2019s esophagus. Gastrointest Endosc. 2019;90(5):707\u2013e171. https:\/\/doi.org\/10.1016\/j.gie.2019.05.030.","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"1041_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cgh.2017.11.044","volume":"16","author":"R Krishnamoorthi","year":"2018","unstructured":"Krishnamoorthi R, Singh S, Ragunathan K, Visrodia K, Wang KK, Katzka DA, et al. Factors Associated With Progression of Barrett\u2019s Esophagus: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16(7):1046\u2013e558. https:\/\/doi.org\/10.1016\/j.cgh.2017.11.044.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1041_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ajg.2012.446","volume":"108","author":"JH Rubenstein","year":"2013","unstructured":"Rubenstein JH, Morgenstern H, Appelman H, Scheiman J, Schoenfeld P, McMahon LF Jr., et al. Prediction of Barrett\u2019s esophagus among men. Am J Gastroenterol. 2013;108(3):353\u201362. https:\/\/doi.org\/10.1038\/ajg.2012.446.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1041_CR26","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cgh.2017.03.004","volume":"15","author":"AP Thrift","year":"2017","unstructured":"Thrift AP, Vaughan TL, Anderson LA, Whiteman DC, El-Serag HB. External Validation of the Michigan Barrett\u2019s Esophagus Prediction Tool. Clin Gastroenterol Hepatol. 2017;15(7):1124\u20136. https:\/\/doi.org\/10.1016\/j.cgh.2017.03.004.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1041_CR27","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1053\/j.gastro.2020.02.037","volume":"158","author":"JH Rubenstein","year":"2020","unstructured":"Rubenstein JH, McConnell D, Waljee AK, Metko V, Nofz K, Khodadost M, et al. Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett\u2019s Esophagus and Early Neoplasia. Gastroenterology. 2020;158(8):2082\u201392. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.037.","journal-title":"Gastroenterology"},{"issue":"5","key":"1041_CR28","doi-asserted-by":"publisher","first-page":"949","DOI":"10.14309\/ajg.0000000000001255","volume":"116","author":"JH Rubenstein","year":"2021","unstructured":"Rubenstein JH, Raghunathan T, Doan C, Schneider J, Zhao W, Metko V, et al. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. Am J Gastroenterol. 2021;116(5):949\u201357. https:\/\/doi.org\/10.14309\/ajg.0000000000001255.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"1041_CR29","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cgh.2018.03.014","volume":"16","author":"AT Kunzmann","year":"2018","unstructured":"Kunzmann AT, Thrift AP, Cardwell CR, Lagergren J, Xie S, Johnston BT, et al. Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol. 2018;16(8):1229\u2013e364. https:\/\/doi.org\/10.1016\/j.cgh.2018.03.014.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1041_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41395-018-0069-9","volume":"113","author":"SH Xie","year":"2018","unstructured":"Xie SH, Ness-Jensen E, Medefelt N, Lagergren J. Assessing the feasibility of targeted screening for esophageal adenocarcinoma based on individual risk assessment in a population-based cohort study in Norway (The HUNT Study). Am J Gastroenterol. 2018;113(6):829\u201335. https:\/\/doi.org\/10.1038\/s41395-018-0069-9.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1041_CR31","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1016\/s2589-7500(19)30216-x","volume":"2","author":"A Rosenfeld","year":"2020","unstructured":"Rosenfeld A, Graham DG, Jevons S, Ariza J, Hagan D, Wilson A, et al. Development and validation of a risk prediction model to diagnose Barrett\u2019s oesophagus (MARK-BE): a case-control machine learning approach. Lancet Digit Health. 2020;2(1):E37\u201348. https:\/\/doi.org\/10.1016\/s2589-7500(19)30216-x.","journal-title":"Lancet Digit Health"},{"issue":"9","key":"1041_CR32","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1016\/j.cgh.2022.08.007","volume":"21","author":"TN Wenker","year":"2023","unstructured":"Wenker TN, Rubenstein JH, Thrift AP, Singh H, El-Serag HB. Development and Validation of the Houston-BEST, a Barrett\u2019s Esophagus Risk Prediction Model Adaptable to Electronic Health Records. Clin Gastroenterol Hepatol. 2023;21(9):2424\u2013e60. https:\/\/doi.org\/10.1016\/j.cgh.2022.08.007.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"1041_CR33","doi-asserted-by":"publisher","first-page":"e00637","DOI":"10.14309\/ctg.0000000000000637","volume":"14","author":"PG Iyer","year":"2023","unstructured":"Iyer PG, Sachdeva K, Leggett CL, Codipilly DC, Abbas H, Anderson K, et al. Development of Electronic Health Record-Based Machine Learning Models to Predict Barrett\u2019s Esophagus and Esophageal Adenocarcinoma Risk. Clin Transl Gastroenterol. 2023;14(10):e00637. https:\/\/doi.org\/10.14309\/ctg.0000000000000637.","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"1041_CR34","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1053\/j.gastro.2023.08.011","volume":"165","author":"JH Rubenstein","year":"2023","unstructured":"Rubenstein JH, Fontaine S, MacDonald PW, Burns JA, Evans RR, Arasim ME, et al. Predicting Incident Adenocarcinoma of the Esophagus or Gastric Cardia Using Machine Learning of Electronic Health Records. Gastroenterology. 2023;165(6):1420\u2013e910. https:\/\/doi.org\/10.1053\/j.gastro.2023.08.011.","journal-title":"Gastroenterology"},{"issue":"4","key":"1041_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/mog.0000000000000938","volume":"39","author":"AT Kunzmann","year":"2023","unstructured":"Kunzmann AT, Rubenstein JH. Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future steps. Curr Opin Gastroenterol. 2023;39(4):320\u20135. https:\/\/doi.org\/10.1097\/mog.0000000000000938.","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"1041_CR36","doi-asserted-by":"publisher","first-page":"e1001780","DOI":"10.1371\/journal.pmed.1001780","volume":"12","author":"CS Ross-Innes","year":"2015","unstructured":"Ross-Innes CS, Debiram-Beecham I, O\u2019Donovan M, Walker E, Varghese S, Lao-Sirieix P, et al. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett\u2019s esophagus: a multi-center case-control study. PLoS Med. 2015;12(1):e1001780. https:\/\/doi.org\/10.1371\/journal.pmed.1001780.","journal-title":"PLoS Med"},{"issue":"10247","key":"1041_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s0140-6736(20)31099-0","volume":"396","author":"RC Fitzgerald","year":"2020","unstructured":"Fitzgerald RC, di Pietro M, O\u2019Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett\u2019s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020;396(10247):333\u201344. https:\/\/doi.org\/10.1016\/s0140-6736(20)31099-0.","journal-title":"Lancet"},{"issue":"4","key":"1041_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cgh.2018.07.043","volume":"17","author":"W Januszewicz","year":"2019","unstructured":"Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, et al. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol. 2019;17(4):647\u2013e561. https:\/\/doi.org\/10.1016\/j.cgh.2018.07.043.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1041_CR39","doi-asserted-by":"publisher","first-page":"e054258","DOI":"10.1136\/bmjopen-2021-054258","volume":"12","author":"R Maroni","year":"2022","unstructured":"Maroni R, Barnes J, Offman J, Scheibl F, Smith SG, Debiram-Beecham I, et al. Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial. BMJ Open. 2022;12(4):e054258. https:\/\/doi.org\/10.1136\/bmjopen-2021-054258.","journal-title":"BMJ Open"},{"issue":"9","key":"1041_CR40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.cgh.2017.02.017","volume":"15","author":"CR Heberle","year":"2017","unstructured":"Heberle CR, Omidvari AH, Ali A, Kroep S, Kong CY, Inadomi JM, et al. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett\u2019s Esophagus With a Minimally Invasive Cell Sampling Device. Clin Gastroenterol Hepatol. 2017;15(9):1397\u2013e4047. https:\/\/doi.org\/10.1016\/j.cgh.2017.02.017.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1041_CR41","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.14309\/ajg.0000000000001336","volume":"116","author":"SS Sami","year":"2021","unstructured":"Sami SS, Moriarty JP, Rosedahl JK, Borah BJ, Katzka DA, Wang KK, et al. Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett\u2019s Esophagus Screening. Am J Gastroenterol. 2021;116(8):1620\u201331. https:\/\/doi.org\/10.14309\/ajg.0000000000001336.","journal-title":"Am J Gastroenterol"},{"key":"1041_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16762","author":"T Aoki","year":"2024","unstructured":"Aoki T, Watson DI, Bulamu NB. Cost-effective identification of Barrett\u2019s esophagus in the community: A first step towards screening. J Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1111\/jgh.16762.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1041_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/s1470-2045(21)00667-7","volume":"23","author":"ND Pilonis","year":"2022","unstructured":"Pilonis ND, Killcoyne S, Tan WK, O\u2019Donovan M, Malhotra S, Tripathi M, et al. Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett\u2019s oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot. Lancet Oncol. 2022;23(2):270\u20138. https:\/\/doi.org\/10.1016\/s1470-2045(21)00667-7.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1041_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s2468-1253(16)30118-2","volume":"2","author":"CS Ross-Innes","year":"2017","unstructured":"Ross-Innes CS, Chettouh H, Achilleos A, Galeano-Dalmau N, Debiram-Beecham I, MacRae S, et al. Risk stratification of Barrett\u2019s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. Lancet Gastroenterol Hepatol. 2017;2(1):23\u201331. https:\/\/doi.org\/10.1016\/s2468-1253(16)30118-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1041_CR45","doi-asserted-by":"publisher","unstructured":"Chien S, Glen P, Penman I, Cruickshank N, Bryce G, Crumley A, et al. Oesophageal cell collection device and biomarker testing to identify high-risk Barrett\u2019s patients requiring endoscopic investigation. Br J Surg. 2024;111(5). https:\/\/doi.org\/10.1093\/bjs\/znae117.","DOI":"10.1093\/bjs\/znae117"},{"key":"1041_CR46","doi-asserted-by":"publisher","unstructured":"Chien S, Glen P, Penman I, Bryce G, Cruickshank N, Miller M, et al. National adoption of an esophageal cell collection device for Barrett\u2019s esophagus surveillance: impact on delay to investigation and pathological findings. Dis Esophagus. 2024;37(5). https:\/\/doi.org\/10.1093\/dote\/doae002.","DOI":"10.1093\/dote\/doae002"},{"issue":"8","key":"1041_CR47","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.14309\/ajg.0000000000000656","volume":"115","author":"PG Iyer","year":"2020","unstructured":"Iyer PG, Taylor WR, Johnson ML, Lansing RL, Maixner KA, Hemminger LL, et al. Accurate Nonendoscopic Detection of Barrett\u2019s Esophagus by Methylated DNA Markers: A Multisite Case Control Study. Am J Gastroenterol. 2020;115(8):1201\u20139. https:\/\/doi.org\/10.14309\/ajg.0000000000000656.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1041_CR48","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.gie.2021.03.937","volume":"94","author":"PG Iyer","year":"2021","unstructured":"Iyer PG, Taylor WR, Slettedahl SW, Lansing RL, Hemminger LL, Cayer FK, et al. Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett\u2019s esophagus in a multisite case-control study. Gastrointest Endosc. 2021;94(3):498\u2013505. https:\/\/doi.org\/10.1016\/j.gie.2021.03.937.","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"1041_CR49","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.cgh.2024.03.003","volume":"22","author":"PG Iyer","year":"2024","unstructured":"Iyer PG, Slettedahl SW, Mahoney DW, Giakoumopoulos M, Olson MC, Krockenberger M, et al. Algorithm Training and Testing for a Nonendoscopic Barrett\u2019s Esophagus Detection Test in Prospective Multicenter Cohorts. Clin Gastroenterol Hepatol. 2024;22(8):1596\u2013e6044. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.003.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1041_CR50","unstructured":"Class 2 Device Recall EsophaCap. US Food & Drug Administration; 2024."},{"issue":"11","key":"1041_CR51","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.14309\/ajg.0000000000002850","volume":"119","author":"HR Moinova","year":"2024","unstructured":"Moinova HR, Verma S, Dumot J, Faulx A, Iyer PG, Canto MI, et al. Multicenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett\u2019s Esophagus and Esophageal Adenocarcinoma. Am J Gastroenterol. 2024;119(11):2206\u201314. https:\/\/doi.org\/10.14309\/ajg.0000000000002850.","journal-title":"Am J Gastroenterol"},{"key":"1041_CR52","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002962","author":"KB Greer","year":"2024","unstructured":"Greer KB, Blum AE, Faulx AL, Deming EM, Hricik LL, Siddiqui H, et al. Nonendoscopic Screening for Barrett\u2019s Esophagus and Esophageal Adenocarcinoma in At-Risk Veterans. Am J Gastroenterol. 2024. https:\/\/doi.org\/10.14309\/ajg.0000000000002962.","journal-title":"Am J Gastroenterol"},{"key":"1041_CR53","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003238","author":"NJ Shaheen","year":"2024","unstructured":"Shaheen NJ, Othman MO, Taunk J, Chang KJ, Jaganmohan S, Yachimski PS, et al. Use of a Two-gene Methylated DNA Biomarker Assay and Non-Endoscopic Balloon for Detection of Barrett\u2019s Esophagus among High-Risk Individuals in a Screening Population. Am J Gastroenterol. 2024. https:\/\/doi.org\/10.14309\/ajg.0000000000003238.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1041_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.gastro.2016.11.001","volume":"152","author":"DK Chan","year":"2017","unstructured":"Chan DK, Zakko L, Visrodia KH, Leggett CL, Lutzke LS, Clemens MA, et al. Breath Testing for Barrett\u2019s Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device. Gastroenterology. 2017;152(1):24\u20136. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.001.","journal-title":"Gastroenterology"},{"issue":"7","key":"1041_CR55","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/gutjnl-2019-320273","volume":"69","author":"Y Peters","year":"2020","unstructured":"Peters Y, Schrauwen RWM, Tan AC, Bogers SK, de Jong B, Siersema PD. Detection of Barrett\u2019s oesophagus through exhaled breath using an electronic nose device. Gut. 2020;69(7):1169\u201372. https:\/\/doi.org\/10.1136\/gutjnl-2019-320273.","journal-title":"Gut"},{"issue":"6","key":"1041_CR56","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/sla.0000000000001101","volume":"262","author":"S Kumar","year":"2015","unstructured":"Kumar S, Huang J, Abbassi-Ghadi N, Mackenzie HA, Veselkov KA, Hoare JM, et al. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma. Ann Surg. 2015;262(6):981\u201390. https:\/\/doi.org\/10.1097\/sla.0000000000001101.","journal-title":"Ann Surg"},{"issue":"9","key":"1041_CR57","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.14309\/ajg.0000000000002812","volume":"119","author":"J Sijben","year":"2024","unstructured":"Sijben J, Rainey L, Maas F, Broeders MJM, Siersema PD, Peters Y. The Public\u2019s Intended Uptake of Hypothetical Esophageal Adenocarcinoma Screening Scenarios: A Nationwide Survey. Am J Gastroenterol. 2024;119(9):1802\u201312. https:\/\/doi.org\/10.14309\/ajg.0000000000002812.","journal-title":"Am J Gastroenterol"},{"key":"1041_CR58","doi-asserted-by":"publisher","unstructured":"Huibertse LJ, Peters Y, Westendorp D, Siersema PD. Unsedated transnasal endoscopy for the detection of Barrett\u2019s esophagus: systematic review and meta-analysis. Dis Esophagus. 2023;36(2). https:\/\/doi.org\/10.1093\/dote\/doac045.","DOI":"10.1093\/dote\/doac045"},{"issue":"4","key":"1041_CR59","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.gie.2018.10.024","volume":"89","author":"J Honing","year":"2019","unstructured":"Honing J, Kievit W, Bookelaar J, Peters Y, Iyer PG, Siersema PD. Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett\u2019s esophagus in patients with GERD symptoms. Gastrointest Endosc. 2019;89(4):712\u2013e223. https:\/\/doi.org\/10.1016\/j.gie.2018.10.024.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"1041_CR60","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/ajg.2009.86","volume":"104","author":"A Bhardwaj","year":"2009","unstructured":"Bhardwaj A, Hollenbeak CS, Pooran N, Mathew A. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett\u2019s esophagus in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2009;104(6):1533\u20139. https:\/\/doi.org\/10.1038\/ajg.2009.86.","journal-title":"Am J Gastroenterol"},{"key":"1041_CR61","doi-asserted-by":"publisher","unstructured":"Vantanasiri K, Kamboj AK, Kisiel JB, Iyer PG. Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma. Mayo Clin Proc. 2024;99(3):459\u2009\u2013\u200973. https:\/\/doi.org\/10.1016\/j.mayocp.2023.07.014","DOI":"10.1016\/j.mayocp.2023.07.014"},{"issue":"4","key":"1041_CR62","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.gie.2019.10.031","volume":"91","author":"S Beg","year":"2020","unstructured":"Beg S, Card T, Warburton S, Rahman I, Wilkes E, White J, et al. Diagnosis of Barrett\u2019s esophagus and esophageal varices using a magnetically assisted capsule endoscopy system. Gastrointest Endosc. 2020;91(4):773\u2013e811. https:\/\/doi.org\/10.1016\/j.gie.2019.10.031.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"1041_CR63","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.cgh.2021.02.008","volume":"20","author":"J Dong","year":"2022","unstructured":"Dong J, Grant C, Vuong B, Nishioka N, Gao AH, Beatty M, et al. Feasibility and Safety of Tethered Capsule Endomicroscopy in Patients With Barrett\u2019s Esophagus in a Multi-Center Study. Clin Gastroenterol Hepatol. 2022;20(4):756\u2013e653. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.008.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1041_CR64","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/gast.2001.20911","volume":"120","author":"JM Poneros","year":"2001","unstructured":"Poneros JM, Brand S, Bouma BE, Tearney GJ, Compton CC, Nishioka NS. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology. 2001;120(1):7\u201312. https:\/\/doi.org\/10.1053\/gast.2001.20911.","journal-title":"Gastroenterology"},{"issue":"2","key":"1041_CR65","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5.","journal-title":"Cell"},{"issue":"4","key":"1041_CR66","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10620-015-3959-3","volume":"61","author":"R Mallick","year":"2016","unstructured":"Mallick R, Patnaik SK, Wani S, Bansal A. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett\u2019s Esophagus. Dig Dis Sci. 2016;61(4):1039\u201350. https:\/\/doi.org\/10.1007\/s10620-015-3959-3.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1041_CR67","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00535-015-1133-5","volume":"51","author":"P Bus","year":"2016","unstructured":"Bus P, Kestens C, Ten Kate FJ, Peters W, Drenth JP, Roodhart JM, et al. Profiling of circulating microRNAs in patients with Barrett\u2019s esophagus and esophageal adenocarcinoma. J Gastroenterol. 2016;51(6):560\u201370. https:\/\/doi.org\/10.1007\/s00535-015-1133-5.","journal-title":"J Gastroenterol"},{"key":"1041_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333364","author":"J Miyoshi","year":"2024","unstructured":"Miyoshi J, Mannucci A, Scarpa M, Gao F, Toden S, Whitsett T, et al. Liquid biopsy to identify Barrett\u2019s oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study. Gut. 2024. https:\/\/doi.org\/10.1136\/gutjnl-2024-333364.","journal-title":"Gut"},{"issue":"24","key":"1041_CR69","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.1158\/1078-0432.Ccr-19-0740","volume":"25","author":"Y Qin","year":"2019","unstructured":"Qin Y, Wu CW, Taylor WR, Sawas T, Burger KN, Mahoney DW, et al. Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma. Clin Cancer Res. 2019;25(24):7396\u2013404. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-0740.","journal-title":"Clin Cancer Res"},{"issue":"43","key":"1041_CR70","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.3748\/wjg.v30.i43.4609","volume":"30","author":"XJ Liu","year":"2024","unstructured":"Liu XJ, Pi GL, Wang S, Kai JD, Yu HF, Shi HW, et al. Plasma DNA methylation detection for early screening, diagnosis, and monitoring of esophageal adenocarcinoma and squamous cell carcinoma. World J Gastroenterol. 2024;30(43):4609\u201319. https:\/\/doi.org\/10.3748\/wjg.v30.i43.4609.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"1041_CR71","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167\u201377. https:\/\/doi.org\/10.1016\/j.annonc.2021.05.806.","journal-title":"Ann Oncol"},{"issue":"10425","key":"1041_CR72","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/s0140-6736(23)02830-1","volume":"403","author":"C Turnbull","year":"2024","unstructured":"Turnbull C, Wald N, Sullivan R, Pharoah P, Houlston RS, Aggarwal A, et al. GRAIL-Galleri: why the special treatment? Lancet. 2024;403(10425):431\u20132. https:\/\/doi.org\/10.1016\/s0140-6736(23)02830-1.","journal-title":"Lancet"},{"key":"1041_CR73","doi-asserted-by":"publisher","unstructured":"Cotner CE, O\u2019Donnell E. Understanding the landscape of multi-cancer detection tests: The current data and clinical considerations. Life (Basel). 2024;14(7). https:\/\/doi.org\/10.3390\/life14070896.","DOI":"10.3390\/life14070896"},{"issue":"6378","key":"1041_CR74","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359(6378):926\u201330. https:\/\/doi.org\/10.1126\/science.aar3247.","journal-title":"Science"},{"issue":"5","key":"1041_CR75","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1053\/j.gastro.2017.12.003","volume":"154","author":"J Dong","year":"2018","unstructured":"Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, et al. Determining Risk of Barrett\u2019s Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology. 2018;154(5):1273\u2013e813. https:\/\/doi.org\/10.1053\/j.gastro.2017.12.003.","journal-title":"Gastroenterology"},{"issue":"8","key":"1041_CR76","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.cgh.2013.12.014","volume":"12","author":"AP Thrift","year":"2014","unstructured":"Thrift AP, Garcia JM, El-Serag HB. A multibiomarker risk score helps predict risk for Barrett\u2019s esophagus. Clin Gastroenterol Hepatol. 2014;12(8):1267\u201371. https:\/\/doi.org\/10.1016\/j.cgh.2013.12.014.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1041_CR77","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clinre.2017.05.005","volume":"42","author":"YQ Xiong","year":"2018","unstructured":"Xiong YQ, Ma SJ, Hu HY, Ge J, Zhou LZ, Huo ST, et al. Comparison of narrow-band imaging and confocal laser endomicroscopy for the detection of neoplasia in Barrett\u2019s esophagus: A meta-analysis. Clin Res Hepatol Gastroenterol. 2018;42(1):31\u20139. https:\/\/doi.org\/10.1016\/j.clinre.2017.05.005.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"1041_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gie.2018.01.032","volume":"88","author":"M Alshelleh","year":"2018","unstructured":"Alshelleh M, Inamdar S, McKinley M, Stewart M, Novak JS, Greenberg RE, et al. Incremental yield of dysplasia detection in Barrett\u2019s esophagus using volumetric laser endomicroscopy with and without laser marking compared with a standardized random biopsy protocol. Gastrointest Endosc. 2018;88(1):35\u201342. https:\/\/doi.org\/10.1016\/j.gie.2018.01.032.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"1041_CR79","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.gie.2020.07.052","volume":"93","author":"MR Struyvenberg","year":"2021","unstructured":"Struyvenberg MR, de Groof AJ, Fonoll\u00e0 R, van der Sommen F, de With PHN, Schoon EJ, et al. Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett\u2019s neoplasia. Gastrointest Endosc. 2021;93(4):871\u20139. https:\/\/doi.org\/10.1016\/j.gie.2020.07.052.","journal-title":"Gastrointest Endosc"},{"key":"1041_CR80","doi-asserted-by":"publisher","unstructured":"Suresh Kumar VC, Harne P, Patthipati VS, Subedi A, Masood U, Sharma A, et al. Wide-area transepithelial sampling in adjunct to forceps biopsy increases the absolute detection rates of Barrett\u2019s oesophagus and oesophageal dysplasia: a meta-analysis and systematic review. BMJ Open Gastroenterol. 2020;7(1). https:\/\/doi.org\/10.1136\/bmjgast-2020-000494.","DOI":"10.1136\/bmjgast-2020-000494"},{"issue":"1","key":"1041_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gie.2021.09.015","volume":"95","author":"DC Codipilly","year":"2022","unstructured":"Codipilly DC, Krishna Chandar A, Wang KK, Katzka DA, Goldblum JR, Thota PN, et al. Wide-area transepithelial sampling for dysplasia detection in Barrett\u2019s esophagus: a systematic review and meta-analysis. Gastrointest Endosc. 2022;95(1):51\u2013e97. https:\/\/doi.org\/10.1016\/j.gie.2021.09.015.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"1041_CR82","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.gie.2021.09.014","volume":"95","author":"NJ Shaheen","year":"2022","unstructured":"Shaheen NJ, Smith MS, Odze RD. Progression of Barrett\u2019s esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis. Gastrointest Endosc. 2022;95(3):410\u2013e81. https:\/\/doi.org\/10.1016\/j.gie.2021.09.014.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"1041_CR83","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.gie.2014.01.009","volume":"79","author":"S Singh","year":"2014","unstructured":"Singh S, Manickam P, Amin AV, Samala N, Schouten LJ, Iyer PG, et al. Incidence of esophageal adenocarcinoma in Barrett\u2019s esophagus with low-grade dysplasia: a systematic review and meta-analysis. Gastrointest Endosc. 2014;79(6):897\u2013909. https:\/\/doi.org\/10.1016\/j.gie.2014.01.009. e4; quiz 83.e1, 83.e3.","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"1041_CR84","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.14309\/ajg.0000000000002818","volume":"119","author":"NJ Shaheen","year":"2024","unstructured":"Shaheen NJ, Odze RD, Singer ME, Salyers WJ, Srinivasan S, Kaul V, et al. Adjunctive Use of Wide-Area Transepithelial Sampling-3D in Patients With Symptomatic Gastroesophageal Reflux Increases Detection of Barrett\u2019s Esophagus and Dysplasia. Am J Gastroenterol. 2024;119(10):1990\u20132001. https:\/\/doi.org\/10.14309\/ajg.0000000000002818.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1041_CR85","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.gie.2017.07.039","volume":"87","author":"PR Vennalaganti","year":"2018","unstructured":"Vennalaganti PR, Kaul V, Wang KK, Falk GW, Shaheen NJ, Infantolino A, et al. Increased detection of Barrett\u2019s esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial. Gastrointest Endosc. 2018;87(2):348\u201355. https:\/\/doi.org\/10.1016\/j.gie.2017.07.039.","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"1041_CR86","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1007\/s10620-020-06412-1","volume":"66","author":"ME Singer","year":"2021","unstructured":"Singer ME, Smith MS. Wide Area Transepithelial Sampling with Computer-Assisted Analysis (WATS(3D)) Is Cost-Effective in Barrett\u2019s Esophagus Screening. Dig Dis Sci. 2021;66(5):1572\u20139. https:\/\/doi.org\/10.1007\/s10620-020-06412-1.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"1041_CR87","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1053\/j.gastro.2017.12.009","volume":"154","author":"S Parasa","year":"2018","unstructured":"Parasa S, Vennalaganti S, Gaddam S, Vennalaganti P, Young P, Gupta N, et al. Development and Validation of a Model to Determine Risk of Progression of Barrett\u2019s Esophagus to Neoplasia. Gastroenterology. 2018;154(5):1282\u2013e92. https:\/\/doi.org\/10.1053\/j.gastro.2017.12.009.","journal-title":"Gastroenterology"},{"issue":"10","key":"1041_CR88","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/apt.15235","volume":"49","author":"AT Kunzmann","year":"2019","unstructured":"Kunzmann AT, Thrift AP, Johnston BT, McManus DT, Gavin AT, Turkington RC, et al. External validation of a model to determine risk of progression of Barrett\u2019s oesophagus to neoplasia. Aliment Pharmacol Ther. 2019;49(10):1274\u201381. https:\/\/doi.org\/10.1111\/apt.15235.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1041_CR89","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.gie.2021.12.034","volume":"95","author":"TH Nguyen","year":"2022","unstructured":"Nguyen TH, Thrift AP, Ketwaroo GA, Du XL, Leon Novelo L, George R, et al. External validation of a model determining risk of neoplastic progression of Barrett\u2019s esophagus in a cohort of U.S. veterans. Gastrointest Endosc. 2022;95(6):1113\u201322. https:\/\/doi.org\/10.1016\/j.gie.2021.12.034.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"1041_CR90","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.gastro.2016.10.041","volume":"152","author":"P Vennalaganti","year":"2017","unstructured":"Vennalaganti P, Kanakadandi V, Goldblum JR, Mathur SC, Patil DT, Offerhaus GJ, et al. Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett\u2019s Esophagus. Gastroenterology. 2017;152(3):564\u2013e704. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.041.","journal-title":"Gastroenterology"},{"key":"1041_CR91","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332095","author":"G Lian","year":"2024","unstructured":"Lian G, Malagola E, Wei C, Shi Q, Zhao J, Hata M, et al. p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett\u2019s oesophagus. Gut. 2024. https:\/\/doi.org\/10.1136\/gutjnl-2024-332095.","journal-title":"Gut"},{"issue":"5","key":"1041_CR92","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10620-019-05586-7","volume":"64","author":"P Snyder","year":"2019","unstructured":"Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA. Aberrant p53 Immunostaining in Barrett\u2019s Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses. Dig Dis Sci. 2019;64(5):1089\u201397. https:\/\/doi.org\/10.1007\/s10620-019-05586-7.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"1041_CR93","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/his.14642","volume":"80","author":"W Januszewicz","year":"2022","unstructured":"Januszewicz W, Pilonis ND, Sawas T, Phillips R, O\u2019Donovan M, Miremadi A, et al. The utility of P53 immunohistochemistry in the diagnosis of Barrett\u2019s oesophagus with indefinite for dysplasia. Histopathology. 2022;80(7):1081\u201390. https:\/\/doi.org\/10.1111\/his.14642.","journal-title":"Histopathology"},{"issue":"10","key":"1041_CR94","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1055\/a-2317-8184","volume":"56","author":"S Menon","year":"2024","unstructured":"Menon S, Norman R, Iyer PG, Ragunath K. Stratification of Barrett\u2019s esophagus surveillance based on p53 immunohistochemistry: a cost-effectiveness analysis by an international collaborative group. Endoscopy. 2024;56(10):727\u201336. https:\/\/doi.org\/10.1055\/a-2317-8184.","journal-title":"Endoscopy"},{"issue":"1","key":"1041_CR95","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.giec.2020.08.007","volume":"31","author":"RF Souza","year":"2021","unstructured":"Souza RF, Spechler SJ. Advances in Biomarkers for Risk Stratification in Barrett\u2019s Esophagus. Gastrointest Endosc Clin N Am. 2021;31(1):105\u201315. https:\/\/doi.org\/10.1016\/j.giec.2020.08.007.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"1041_CR96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/2153-3539.163987","volume":"6","author":"JW Prichard","year":"2015","unstructured":"Prichard JW, Davison JM, Campbell BB, Repa KA, Reese LM, Nguyen XM, et al. TissueCypher(\u2122): A systems biology approach to anatomic pathology. J Pathol Inf. 2015;6:48. https:\/\/doi.org\/10.4103\/2153-3539.163987.","journal-title":"J Pathol Inf"},{"issue":"12","key":"1041_CR97","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.cgh.2022.02.033","volume":"20","author":"PG Iyer","year":"2022","unstructured":"Iyer PG, Codipilly DC, Chandar AK, Agarwal S, Wang KK, Leggett CL, et al. Prediction of Progression in Barrett\u2019s Esophagus Using a Tissue Systems Pathology Test: A Pooled Analysis of International Multicenter Studies. Clin Gastroenterol Hepatol. 2022;20(12):2772\u2013e98. https:\/\/doi.org\/10.1016\/j.cgh.2022.02.033.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"1041_CR98","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1053\/j.gastro.2023.07.029","volume":"165","author":"AM Khoshiwal","year":"2023","unstructured":"Khoshiwal AM, Frei NF, Pouw RE, Smolko C, Arora M, Siegel JJ, et al. The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia. Gastroenterology. 2023;165(5):1168\u2013e796. https:\/\/doi.org\/10.1053\/j.gastro.2023.07.029.","journal-title":"Gastroenterology"},{"issue":"2","key":"1041_CR99","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1158\/1055-9965.Epi-16-0640","volume":"26","author":"RJ Critchley-Thorne","year":"2017","unstructured":"Critchley-Thorne RJ, Davison JM, Prichard JW, Reese LM, Zhang Y, Repa K, et al. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett\u2019s Esophagus. Cancer Epidemiol Biomarkers Prev. 2017;26(2):240\u20138. https:\/\/doi.org\/10.1158\/1055-9965.Epi-16-0640.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1041_CR100","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2147\/ceor.S221741","volume":"11","author":"J Hao","year":"2019","unstructured":"Hao J, Critchley-Thorne R, Diehl DL, Snyder SR. A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett\u2019s Esophagus. Clinicoecon Outcomes Res. 2019;11:623\u201335. https:\/\/doi.org\/10.2147\/ceor.S221741.","journal-title":"Clinicoecon Outcomes Res"},{"issue":"3","key":"1041_CR101","doi-asserted-by":"publisher","first-page":"E348","DOI":"10.1055\/a-1326-1533","volume":"9","author":"DL Diehl","year":"2021","unstructured":"Diehl DL, Khara HS, Akhtar N, Critchley-Thorne RJ. TissueCypher Barrett\u2019s esophagus assay impacts clinical decisions in the management of patients with Barrett\u2019s esophagus. Endosc Int Open. 2021;9(3):E348\u201355. https:\/\/doi.org\/10.1055\/a-1326-1533.","journal-title":"Endosc Int Open"},{"issue":"6","key":"1041_CR102","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ajg.2015.152","volume":"110","author":"S Eluri","year":"2015","unstructured":"Eluri S, Brugge WR, Daglilar ES, Jackson SA, Styn MA, Callenberg KM, et al. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett\u2019s Esophagus. Am J Gastroenterol. 2015;110(6):828\u201334. https:\/\/doi.org\/10.1038\/ajg.2015.152.","journal-title":"Am J Gastroenterol"},{"key":"1041_CR103","doi-asserted-by":"publisher","unstructured":"Eluri S, Klaver E, Duits LC, Jackson SA, Bergman JJ, Shaheen NJ. Validation of a biomarker panel in Barrett\u2019s esophagus to predict progression to esophageal adenocarcinoma. Dis Esophagus. 2018;31(11). https:\/\/doi.org\/10.1093\/dote\/doy026.","DOI":"10.1093\/dote\/doy026"},{"issue":"1","key":"1041_CR104","doi-asserted-by":"publisher","first-page":"e000268","DOI":"10.1136\/bmjgast-2018-000268","volume":"6","author":"AJ Trindade","year":"2019","unstructured":"Trindade AJ, McKinley MJ, Alshelleh M, Levi G, Stewart M, Quinn KJ, et al. Mutational load may predict risk of progression in patients with Barrett\u2019s oesophagus and indefinite for dysplasia: a pilot study. BMJ Open Gastroenterol. 2019;6(1):e000268. https:\/\/doi.org\/10.1136\/bmjgast-2018-000268.","journal-title":"BMJ Open Gastroenterol"},{"key":"1041_CR105","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003030","author":"SE Laun","year":"2024","unstructured":"Laun SE, Kann L, Braun J, Gilbert S, Lunz D, Pierre F, et al. Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett\u2019s Esophagus. Am J Gastroenterol. 2024. https:\/\/doi.org\/10.14309\/ajg.0000000000003030.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1041_CR106","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2023.08.041","volume":"165","author":"JH Rubenstein","year":"2023","unstructured":"Rubenstein JH, Stachler MD. TSP-9: A Barrett\u2019s Esophagus Biomarker Better Than Pathologists? Gastroenterology. 2023;165(5):1106\u20137. https:\/\/doi.org\/10.1053\/j.gastro.2023.08.041.","journal-title":"Gastroenterology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-026-01041-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-026-01041-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-026-01041-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:32:34Z","timestamp":1781645554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-026-01041-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1007\/s11894-026-01041-6","relation":{},"ISSN":["1534-312X"],"issn-type":[{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed byany of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"Dr. Strauss Starling reports grants from Lucid, outside the submitted work. Dr. White has nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}